Point and Figure Charting Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Point and Figure Charting

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Judy who wrote (9906)	11/19/1998 3:34:00 PM
From: Anthony Wong	Read Replies (1) of 34802

[Amended] Judy, you asked me to keep you updated about IMNX. Faber reported on CNBC that Enbrel is soon to be launched and company expects great sales from this product, co. has bought back $millions (???) worth of drugs from its manufacturer (cost of drug is 1/5 of what IMNX is selling it for). Sales is said to be above analysts expectations. That's the gist of it. P.S. It seemed our posts crossed. I agree with your comments at the pharma news thread.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next